- Report
- September 2024
- 158 Pages
North America
From €2271EUR$2,500USD£1,961GBP
- Report
- September 2024
- 162 Pages
Asia Pacific
From €2271EUR$2,500USD£1,961GBP
- Report
- May 2024
- 65 Pages
Global
From €2226EUR$2,450USD£1,921GBP
- Report
- November 2023
- 79 Pages
Global
From €4497EUR$4,950USD£3,882GBP
- Report
- September 2023
- 63 Pages
Asia Pacific
From €4497EUR$4,950USD£3,882GBP
- Report
- April 2023
- 57 Pages
Asia Pacific
From €4497EUR$4,950USD£3,882GBP
- Report
- April 2023
- 78 Pages
Global
From €4497EUR$4,950USD£3,882GBP
- Report
- December 2022
- 36 Pages
Global
From €2226EUR$2,450USD£1,921GBP
- Report
- December 2022
- 24 Pages
Global
From €2226EUR$2,450USD£1,921GBP
- Report
- February 2022
- 55 Pages
United States
From €2226EUR$2,450USD£1,921GBP
- Report
- February 2022
- 45 Pages
United States
From €2226EUR$2,450USD£1,921GBP
- Report
- November 2020
- 63 Pages
Global
- Report
- August 2020
- 74 Pages
Global
From €2725EUR$3,000USD£2,353GBP
- Report
- April 2020
- 65 Pages
Global
- Report
- September 2024
- 150 Pages
Global
From €2716EUR$2,990USD£2,345GBP
- Report
- November 2022
- 276 Pages
Global
From €3407EUR$3,750USD£2,941GBP
- Report
- May 2025
- 110 Pages
North America
From €4315EUR$4,750USD£3,725GBP
- Report
- February 2025
- 200 Pages
Global
From €4079EUR$4,490USD£3,521GBP
- Report
- January 2025
- 291 Pages
Global
From €4542EUR$5,000USD£3,921GBP
- Report
- January 2025
- 286 Pages
Global
From €4542EUR$5,000USD£3,921GBP

The COVID 19 Diagnostics market is a rapidly growing sector of the healthcare industry. It is focused on the development and production of tests and other diagnostic tools to detect the presence of the virus. These tests are used to identify individuals who have been infected with the virus, as well as those who may have been exposed to it. The market is also focused on the development of treatments and vaccines to combat the virus.
The Diagnostics market is driven by the need for rapid and accurate testing, as well as the need for treatments and vaccines. This has led to an increase in investment in the sector, as well as the development of new technologies and products.
Companies in the COVID 19 Diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more